Evidence map›Paper›PMID 35316095›Full record

ArticleScience signaling2022

Biased agonists of the chemokine receptor CXCR3 differentially signal through Gα

Kevin Zheng, Jeffrey S Smith, Dylan S Eiger, Anmol Warman, Issac Choi, Christopher C Honeycutt, Noelia Boldizsar, Jaimee N Gundry, Thomas F Pack, Asuka Inoue and 2 more

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CXCL10 Regulates Pressure Overload-Induced Heart Failure.JACC. Basic to translational science · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Arrestins: A Small Family of Multi-Functional Proteins.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Keras/TensorFlow in Drug Design for Immunity Disorders.International journal of molecular sciences · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Kevin ZhengDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-1437-2820
Jeffrey S SmithHarvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-2840-2899
Dylan S EigerDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0001-9572-6282
Anmol WarmanDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0001-5564-6747
Issac ChoiDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Christopher C HoneycuttDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0003-1813-3576
Noelia BoldizsarDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0003-0299-4697
Jaimee N GundryDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-8978-3229
Thomas F PackDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-1240-8324
Asuka InoueDepartment of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.ORCID 0000-0003-0805-4049
Marc G CaronDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0003-0172-2710
Sudarshan RajagopalDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID 0000-0002-3443-5040
Duke Medical Center · USDuke University · USBrigham and Women's Hospital · USHarvard University · USTohoku Medical and Pharmaceutical University · JP

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Akt/GSK-3 Signaling Cascade and the Actions of DopamineR37MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2011 to 2020
$6.4M
Biasing CXCR3 Signaling to Modulate the Inflammatory ResponseR01GM122798 · NIGMS · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN · 2017 to 2025
$3.2M
Noncanonical Receptor Signaling in Pulmonary Arterial HypertensionK08HL114643 · NHLBI · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN K · 2013 to 2017
$607k
Dissecting the Distinct Arrestin Signaling Capabilities of the Short and Long Dopamine D2 Receptors as a Paradigm for Psychostimulant Addiction TreatmentF31DA041160 · NIDA · DUKE UNIVERSITY · PI PACK, THOMAS FRANKLIN · 2016 to 2017
$67k
NHLBI NIH HHS K08 HL114643NIDA NIH HHS F31 DA041160NIGMS NIH HHS R01 GM122798NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM145449NIMH NIH HHS R37 MH073853
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors and signal through the proximal effectors, G proteins and β-arrestins, to influence nearly every biological process. The G protein and β-arrestin signaling pathways have largely been considered separable; however, direct interactions between Gα proteins and β-arrestins have been described that appear to be part of a distinct GPCR signaling pathway. Within these complexes, Gα

Indexed as

GTP-Binding ProteinsReceptors, G-Protein-Coupledbeta-Arrestin 1beta-ArrestinsSignal Transductionbeta-Arrestin 1beta-ArrestinsGTP-Binding ProteinsReceptors, G-Protein-Coupled

Identifiers

PMID35316095
PMCPMC9890572
OpenAlexW4220783597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.